AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $269,000 | -23.8% | 399,800 | -7.1% | 0.00% | 0.0% |
| Q1 2019 | $353,000 | -47.7% | 430,500 | +2.0% | 0.00% | -50.0% |
| Q4 2018 | $675,000 | -48.2% | 422,000 | +7.2% | 0.00% | -33.3% |
| Q3 2018 | $1,302,000 | +45.5% | 393,500 | -0.7% | 0.00% | +50.0% |
| Q2 2018 | $895,000 | -15.0% | 396,200 | +9.1% | 0.00% | -33.3% |
| Q1 2018 | $1,053,000 | +29.8% | 363,100 | +24.9% | 0.00% | +50.0% |
| Q4 2017 | $811,000 | +140.7% | 290,738 | +214.7% | 0.00% | +100.0% |
| Q3 2017 | $337,000 | – | 92,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,590,673 | $1,399,000 | 1.00% |
| Deer VI & Co. LLC | 675,242 | $365,000 | 0.28% |
| Sarissa Capital Management LP | 1,700,000 | $917,000 | 0.25% |
| NEA Management Company, LLC | 10,362,694 | $5,596,000 | 0.22% |
| Perceptive Advisors | 3,108,808 | $1,678,000 | 0.12% |
| Cormorant Asset Management, LP | 1,087,715 | $587,000 | 0.08% |
| 683 Capital Management, LLC | 1,000,000 | $540,000 | 0.04% |
| Spark Investment Management LLC | 95,800 | $51,000 | 0.00% |
| Elgethun Capital Management | 10,000 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,738 | $8,000 | 0.00% |